Robert Schultz |
Dr. Jay Gruhlkey

Exploring ideas, leadership, and impact through
healthcare, business, and life.

With decades of experience in healthcare and business, Robert Schultz and Dr. Jay Gruhlkey co-founded Direct Allergy, LLC to redefine allergy services. Their leadership brings accessible, reliable, and clinically effective solutions to physicians nationwide to improve patient outcomes in allergy and immunotherapy care.

Robert S. Schultz


True innovation happens at the intersection of industries where experience meets bold execution. I believe in building scalable solutions that challenge norms and create lasting impact.

ABOUT

Robert S. Schultz

Robert Schultz is the Co-Founder and CEO of Direct Allergy, a nationally recognized leader in allergy immunotherapy services. With over three decades of executive success across both the pharmaceutical (Johnson & Johnson, Eli Lilly, GSK) and automotive (Ford) sectors, Robert is known as a cross-industry leader, market disruptor, and innovator.

ABOUT

Dr. Jay L. Gruhlkey

Dr. Jay L. Gruhlkey is a nationally recognized leader in allergy and immunology, with decades of experience shaping clinical practice, physician training, and patient care. He is the Past President of the Pan American Allergy Society, once the largest society for primary care physicians implementing allergen immunotherapy clinics.


Medicine is at its best when knowledge is shared and patients are empowered. I believe in training physicians to not only treat but to truly transform patient care.

About Direct Allergy

Direct Allergy, LLC is a medical service organization dedicated to improving patient access to advanced allergy care. With more than six years of proven experience and operations across seven states, we partner with physicians to deliver on-site allergy testing and customized immunotherapy treatments directly within their practices.

Our Approach

At the core of our model is the Modified Quantified Testing (MQT) skin test, performed in physician offices through our allergy service centers. Using these results, individualized immunotherapy treatments are designed to address each patient’s unique allergies, providing a path toward long-term relief and improved quality of life.

Our Story

Founded in 2012 and headquartered in Erie, Pennsylvania, Direct Allergy has grown into a trusted partner for both primary care providers and specialists. Over the years, our services have expanded while maintaining a commitment to clinical quality, operational excellence, and patient-centered results.

Our Expertise

Our diverse management team and board of advisors bring together decades of experience in healthcare, leadership, business management, and operations. This blend of expertise ensures physicians and patients receive the highest standards of professionalism, knowledge, and care.

Our Mission

Direct Allergy’s mission is to make advanced allergy testing and treatment more accessible, reliable, and effective for the communities we serve.

Innovation, Education, and Community at Work / Making a Difference

Direct Allergy is proud to be recognized not only for advancing allergy care but also for its contributions to education, innovation, and community growth. Our commitment to corporate citizenship is reflected in partnerships and recognitions that extend our mission beyond the clinic.

1.

Penn State University Corporate Partner of the Year

Recognized for meaningful collaboration and support of student innovation.

2.

Educational Partnerships

Ongoing collaborations with students and universities to promote learning, research, and healthcare innovation.

3.

Commonwealth of Pennsylvania Equity Investment

Acknowledged as a trusted partner driving forward healthcare innovation and accessibility.

Overview

Because competence and experience matter!

Featured Interviews

Conversations on Leadership, Healthcare, and Innovation

Robert and Jay have been invited to share their perspectives through interviews on healthcare and allergy. These
conversations highlight their experiences, lessons learned, and vision for advancing patient care and
strengthening physician support.

Dr. Jay L. Gruhlkey featured on Ideamensch

Dr. Jay L. Gruhlkey shared his ideas on various aspects of their professional life on the renowned platform Ideamensch, which publishes for entrepreneurs, makers, and doers.

Robert Schutlz featured on Ideamensch

Robert Schutlz shared his ideas on various aspects of their professional life on the renowned platform Ideamensch, which publishes for entrepreneurs, makers, and doers.

Beyond the Office

Robert and Jay value balance and fulfillment not only in their professional lives but also in their personal journeys. Outside of leading and innovating in healthcare, they enjoy exploring new places, engaging in meaningful activities, and pursuing passions that bring them joy and perspective.

Frequently Asked Questions

  • Direct Allergy is a Medical Service Organization that contracts with Primary Care Physicians to bring allergy testing and treatment in-house at point of care.

  • Direct Allergy partners with qualified (medium to large) healthcare systems using successful integration processes to deliver “best in class” physician support services for patients who suffer from moderate to severe allergies including allergic asthma. Direct Allergy, in-concert with their clients generate significant incremental and sustainable revenue for the healthcare organization by providing convenient, comprehensive, and customized allergy services at “Point of Care” without disrupting current practice operations and patient flow.

  • Direct Allergy is a “complete turn-key operation” designed to enhance your practice’s clinical offerings without disrupting current operations.

  • Your practice will be able to offer a value-added service, providing convenience to your patients and assistance with retention – ultimately increasing your practice’s revenue.

  • Yes. In fact, not only is Allergen Immunotherapy Testing and Treatment within the scope of Primary Care, currently over 51,000 PCPs offer the services within the U.S. That far exceeds the number of Allergists that also offer similar services. The National Procedure Institute, who is owned by The Texas Academy of Family Physicians supports allergy testing and treatment for primary carry physicians as well as many other procedures.

  • Option 1: Inclusive, meaning DA absorbs the Start-up Package Costs
    Option 2: Non-Inclusive, meaning DA & Client Split the Start-up Package Costs

  • If the Direct Allergy nurse is not available or able to address a question, which is highly unlikely, there is easy access to the Direct Allergy’s Clinical Manager of perations, Direct Allergy’s Chief Medical Officer, and Direct Allergy’s Billing & Coding hotline.

  • It depends on the # of active patients within your practice. Finding suitable space that is not being optimized is the best course of action. Typically, we need approximately 100 to 250 square feet. In addition, utilizing a “Cart Program” format also helps manage the space program as “ready carts” w/ all supplies are wheeled to shared rooms when necessary.

Say 👋 to Robert Schultz & Dr. Jay Gruhlkey!

We’d love to hear from you.

Whether you’re a physician ready to bring testing and treatment into your practice, a patient searching for answers, or a partner exploring collaboration, we’re here to listen and help.

Reach out today and let’s start the conversation.

This field is for validation purposes and should be left unchanged.
Scroll to Top

Dr. Jay L. Gruhlkey is Co-Founder and Chief Medical Officer of Direct Allergy, LLC, and a practicing physician in New Braunfels, TX. Widely respected in Allergy and Immunology, he has served as Past-President of the Pan American Allergy Society and has trained thousands of doctors nationwide in allergy testing and treatment through the National Procedure Institute.

Dr. Gruhlkey began his medical career after earning a B.S. in Chemistry from Texas A&M University and an M.D. from The University of Texas Health Science Center–Houston. He completed his Family Medicine residency at Southwest Memorial Hospital, where he was Chief Resident. His contributions to medicine have been recognized with the Mead Johnson Award for Graduate Medical Education and the AMA Foundation Leadership Award. In addition to clinical practice, he consults on medical and legal matters and serves on several healthcare boards.

Robert Schultz is an accomplished executive, cross-industry leader, and market disruptor with over 3 decades of national award-winning achievements within both Field Sales & Field Sales Management across Fortune 100 companies and emerging healthcare ventures. With over 30 years of experience spanning two major industries—pharmaceuticals (ie. Johnson & Johnson, Eli Lilly, GSK-Reliant) and automotive manufacturing (Ford Motor Company)—Robert brings a unique, cross-disciplinary perspective to healthcare innovation.

Robert began his career in 1987 at Ford Motor Company’s World Headquarters and ended it in Cleveland, OH. He enjoyed four promotions in only four years’ time. He then transitioned to the pharmaceutical industry for a 2-decade cycle with heavy developmental movement with major players like Johnson & Johnson, Eli Lilly, GSK, and Daiichi-Sankyo. His roles included Regional Business Manager, Manager, Research & Consulting, District Sales Manager, Assoc. Manager, Managed Care Analyst, Assoc. Manager, Neuroscience & PCP Training & Development, Corporate Auditor, Managed Care.  In 2011, with the backing of Ben Franklin Technology Partners & his old employer’s Co-Founder (GSK-Reliant), Schultz co-founded and became CEO of Direct Allergy, LLC, where he has transformed a once-fragmented sector into a scalable, patient-focused allergy care platform geared for the large primary care health networks that are now housed within the large healthcare systems (IDNs) nationwide. He led the development and commercialization of the Direct Allergy (DA) service model, navigating regulatory hurdles, the pandemic-era, and the capital markets crisis.  The DA service model has been pressure tested across seven states and 52 + clinical sites, and the company is debt-free.  His commitment to strategic execution, academic collaboration, and community goodwill earned the company the Corporate Partner of the Year Award from Penn State University (Erie Campus) in 2021. Today, with the Black Swan events behind and proof of concept successfully complete, Robert, along with the Direct Allergy Board of Managers, have the company positioned for a positive transition for next level funding.